Correvio Pharma (CORV) Short Interest Ratio & Short Volume → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free CORV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Correvio Pharma Short Interest DataCurrent Short Volume2,120,000 sharesPrevious Short Volume2,310,000 sharesChange Vs. Previous Month-8.23%Dollar Volume Sold Short$876,196.00Short Interest Ratio / Days to Cover0.3Last Record DateMay 15, 2020Outstanding Shares66,191,000 sharesFloat Size61,320,000 sharesShort Percent of Float3.46%Today's Trading Volume0 sharesAverage Trading Volume5,353,682 sharesToday's Volume Vs. Average0% Short Selling Correvio Pharma ? Sign up to receive the latest short interest report for Correvio Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCORV Short Interest Over TimeCORV Days to Cover Over TimeCORV Percentage of Float Shorted Over Time Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Correvio Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20202,120,000 shares $876,196.00 -8.2%3.5%0.3 $0.41 4/30/20202,310,000 shares $912,912.00 -38.6%3.8%0.3 $0.40 4/15/20203,760,000 shares $1.45 million +10.6%6.1%0.6 $0.39 3/31/20203,400,000 shares $1.32 million -25.4%6.3%0.5 $0.39 3/13/20204,556,200 shares $1.41 million +44.2%9.2%0.4 $0.31 2/28/20203,160,000 shares $1.45 million +22.0%6.4%0.4 $0.46 2/14/20202,590,000 shares $801,605.00 -1.9%5.3%0.5 $0.31 1/31/20202,640,000 shares $880,704.00 +10.9%5.4%0.8 $0.33 1/15/20202,380,000 shares $904,400.00 +30.1%4.8%0.8 $0.38 12/31/20191,830,000 shares $750,300.00 +99.5%3.7%0.7 $0.41 CORV Short Interest - Frequently Asked Questions What is Correvio Pharma's current short interest? Short interest is the volume of Correvio Pharma shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 2,120,000 shares of CORV short. 3.46% of Correvio Pharma's shares are currently sold short. Learn More on Correvio Pharma's current short interest. What is a good short interest percentage for Correvio Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.46% of Correvio Pharma's floating shares are currently sold short. Is Correvio Pharma's short interest increasing or decreasing? Correvio Pharma saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 2,120,000 shares, a drop of 8.2% from the previous total of 2,310,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Correvio Pharma's float size? Correvio Pharma currently has issued a total of 66,191,000 shares. Some of Correvio Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Correvio Pharma currently has a public float of 61,320,000 shares. How does Correvio Pharma's short interest compare to its competitors? 3.46% of Correvio Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Correvio Pharma: Acasti Pharma Inc. (0.06%), Forte Biosciences, Inc. (0.09%), Sol-Gel Technologies Ltd. (0.10%), Spruce Biosciences, Inc. (0.74%), Lexaria Bioscience Corp. (3.70%), Aprea Therapeutics, Inc. (2.01%), Qilian International Holding Group Limited (0.78%), DURECT Co. (3.19%), Iterum Therapeutics plc (7.50%), Eyenovia, Inc. (11.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.57 billion), Match Group, Inc. ($3.08 billion), Wayfair Inc. ($2.66 billion), Tesla, Inc. ($2.60 billion), The Clorox Company ($2.52 billion), The Charles Schwab Co. ($2.39 billion), DexCom, Inc. ($2.39 billion), International Flavors & Fragrances Inc. ($1.88 billion), The Kroger Co. ($1.78 billion), and Snap Inc. ($1.66 billion). View all of the most shorted stocks. What does it mean to sell short Correvio Pharma stock? Short selling CORV is an investing strategy that aims to generate trading profit from Correvio Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Correvio Pharma? A short squeeze for Correvio Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CORV, which in turn drives the price of the stock up even further. How often is Correvio Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CORV, twice per month. The most recent reporting period available is May, 15 2020. More Short Interest Resources from MarketBeat Related Companies: ACST Short Interest Data FBRX Short Interest Data SLGL Short Interest Data SPRB Short Interest Data LEXX Short Interest Data APRE Short Interest Data QLI Short Interest Data DRRX Short Interest Data ITRM Short Interest Data EYEN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CORV) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets